Work

Additional file 8: Figure S2. of Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer

Year: 2016

Type: article

Abstract: Heatmap depicting DNA damage gene expression across treatment cohorts. Color bar indicates log-fold expression change compared to control tumors. (PDF 92 kb)

Source: Figshare

DOI: 10.6084/m9.figshare.4336403

Authors: Becker, Marc, Hou, Xiaonan, Tienchaianada, Piyawan, Haines, Brian, Harrington, Sean, Weroha, S., Sathyanarayanan, Sriram, Haluska, Paul

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7138049561

FWCI:

Cites:

Cited by:

Related to: 10